William Edward Motzing Jr. (August 19, 1937 – January 30, 2014) was an American composer, conductor, arranger and trombonist best known for the award-winning film and television scores and gold and platinum pop album arrangements he wrote in Australia.[1] He was a jazz lecturer and the Director of Jazz Studies at the Sydney Conservatorium of Music over a period of 40 years.[2]
Early life and career
Born in Pittsburgh, PA, William Motzing attended the Eastman School of Music in Rochester, New York,[3] alongside Ron Carter and Chuck Mangione who would also become notable musicians. He gained his bachelor's degree at Eastman in 1959, and in 1960 a master's degree from the Manhattan School of Music in New York City.[4]
William Motzing had over 30 Australian film and TV soundtracks to his name,[7] including Newsfront, (which opened the London Film Festival and was the first Australian film to screen at the New York Film Festival), Young Einstein (for which he won the Australian Film Institute (AFI) Award for best original music score[8] and the APRA Music Award), The Return of Captain Invincible, starring Alan Arkin and Christopher Lee[9] and The Quiet American (2002). He was nominated for five AFI awards.
He was a lifelong proponent of the Schillinger System. His students included Jon Rose (violin, historian, composition) and Nigel Westlake (composer, performer, conductor).
Health
William Motzing was misdiagnosed with Parkinson's Disease in 2008.[3] In 2013, his neurologist re-diagnosed his condition as Shy–Drager syndrome (SDS). SDS is a rare, aggressive disease that halts all the major organs of the body, for which there is no known cure.
He continued to teach theory, arranging, modern jazz history, improvisation and ensembles at the Sydney Conservatorium of Music, as he had done since 1971. After retiring in 2011, he returned to New York to live with the family of his son, William John Motzing Jr., while he battled symptoms of SDS including paralysis throughout the body. He died peacefully from complications of the disease on January 30, 2014.[1]